跳至主要内容
临床试验/JPRN-UMIN000020358
JPRN-UMIN000020358已完成未知

Preliminary study on recombinant human soluble thrombomodulin (rTM) administration for treatment of pneumonia-induced acute respiratory distress syndrome (ARDS) complicated with disseminated intravascular coagulation(DIC) and sepsis, including avian influenza virus infection - Recombinant human soluble thrombomodulin (rTM) for treatment of pneumonia-induced ARDS complicated with DIC and sepsis, including avian influenza virus infection

ational Hospital for Pediatrics, Nanoi, Vietnam0 个研究点目标入组 3 人开始时间: 2015年12月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1months-old 至 180months-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fulfill any of the followings are excluded 1. Patients with severe renal dysfunction (creatinine clearance < 10mL/min) 2. Patients with bleeding symptoms. 3. Patients whom the treating doctor deems, for any reason, to be ineligible.

研究者

发起方
ational Hospital for Pediatrics, Nanoi, Vietnam

相似试验

Preliminary study on recombinant human soluble... | 临床试验